Introduction
TC-PTP was one of the ®rst members identi®ed from the protein tyrosine phosphatase (PTP) family. Although originally cloned from a human cDNA Tcell library, it is ubiquitously expressed at all stages of mammalian development and in most adult tissues (Cool et al., 1989 , Mosinger et al., 1992 , IbarraSaÂ nchez et al., 2000 , Tonks and Neel, 2001 ). TC-PTP contains a nuclear localization signal at its carboxyl terminus that localizes the enzyme to the nucleus (Tillmann et al., 1994; Lorenzen et al., 1995) . This exposes the enzyme to a unique set of potential nuclear substrates that may play a role in regulating the cell cycle. Recently, it has been suggested that the rat homologue of TC-PTP associates with chromatin in the nucleus, and phosphorylation by a casein kinaselike enzyme disrupts this association (Nambirajan et al., 2000) . Furthermore, it has been shown that TC-PTP associates through its carboxyl terminus with the p97 nuclear import factor (Tiganis et al., 1997) . Additional studies have also shown that TC-PTP mRNA levels¯uctuate during the cell cycle, increasing in G0 and early G1 phase, and decreasing for the rest of the cell cycle (Tillmann et al., 1994; Nambirajan et al., 1995) . Finally, overexpression studies suggested that TC-PTP might cause an increase in cell proliferation (Radha et al., 1997) . Together these results led us to propose that TC-PTP may play a role in regulation of cell proliferation and cell cycle.
Cell cycle progression is controlled by cyclin dependent kinases (CDKs) (Sherr, 1996) that are activated by their association with cyclins and negatively regulated by CDK inhibitors (CKIs) Vidal and Ko, 2000) . The control of mammalian cell proliferation by extracellular signals (mitogens) takes place in the mid-to late G1 phase of the cell cycle and is integrated through dierent signaling pathways. The best characterized is the Ras/ Raf kinase/MAPK pathway. Activated forms of Raf can lead to transformation and moderated activity of Raf kinase activity promotes proliferation by inducing cyclin D1 and DNA synthesis (Serrano et al., 1997 , Sewing et al., 1997 , Woods et al., 1997 , Kerkho and Rapp, 1998 . A second major pathway involves PI3 kinase, and its inactivation has been shown to cause down-regulation of cyclin D1 expression, whereas constitutively active Akt/PKB upregulates it (Muise-Helmericks et al., 1998; Gille and Downward, 1999) . Finally, it has recently been shown that dominant negative forms of the NF-kB transcrip-tion factor are associated with a delay in G1 phase progression (Bargou et al., 1997 , Grumont et al., 1998 . Furthermore, NF-kB is required for cyclin D1 transcriptional initiation and phosphorylation of the retinoblastoma protein (RB). Indeed the absence of NF-kB activity causes a reduction in cell proliferation in conjunction with lower levels of cyclin D1 (Guttridge et al., 1999) . The requirement of several signaling pathways for the normal regulation of the cell cycle ensures that cells receive the right stimuli before progressing through the cell cycle.
In order to gain insight into the putative role of TC-PTP on cell proliferation and the cell cycle, we generated TC-PTP7/7 primary MEFs as well as established cell lines. Their phenotypic characterization demonstrated that both TC-PTP7/7 MEFs and cell lines have a reduced rate of proliferation. We show that this slow rate of proliferation in TC-PTP7/7 cells is due to a delayed expression of cyclin D1 and degradation of the CKI, p27
KIP1
. The defective expression of cyclin D1 caused a delayed activation of CDK2 and inactivation of RB. The major consequence observed in these cells is the delay in the transition to the S phase. Furthermore, there are no apparent defects in the activation of the MAPK and PI3 kinase/Akt/PKB pathways between TC-PTP+/+ and TC-PTP7/7 cells. In contrast, TC-PTP7/7 cells present a reduced activation of NF-kB transcription factor and defective IKKb activity. These results indicate that TC-PTP is required for NF-kB-induced cyclin D1 expression necessary to promote G1 phase progression.
Results

TC-PTP7/7 murine embryonic fibroblasts proliferate slower than TC-PTP+/+ cells
To de®ne the biological function of TC-PTP in cell proliferation, we isolated wild-type and TC-PTP7/7 MEFs from 14 day old mouse embryos. Primary MEFs were used within the six initial passages, and were maintained in culture to obtain spontaneously immortalized cell lines. Genotyping of the primary MEFs and the cell lines was performed by Southern blot analysis; the upper band of 7.6 kb represents the targeted TC-PTP allele and the wild-type allele is shown by the lower band of 5.2 kb (Figure 1a,b) . We con®rmed the complete absence of the protein in the TC-PTP7/7 cells by immunoblotting with a monoclonal antibody directed against TC-PTP. Indeed, the absence of the 45-kDa band in TC-PTP7/7 primary MEFs and cell lines was observed (Figure 1c,d) . Proliferation of the primary MEFs and cell lines were then tested using MTT assays. The results indicated that TC-PTP7/7 primary MEFs have a much slower proliferation rate (*30%) compared to TC-PTP+/+ cells (Figure 2a) . Similar results were obtained with the established cell lines EFM7+/+ and EFM47/7 (Figure 2b ).
Slow G1-phase progression in TC-PTP7/7 cells
In order to explore whether the slower proliferation of TC-PTP7/7 cells was due to a defect in one particular phase of the cell cycle, we evaluated the cell cycle progression in EFM7+/+ and EFM47/7 cells by¯uorescence activated cell sorter (FACS) analysis. Interestingly, EFM47/7 cells exhibit a longer G1 phase compared to the EFM7+/+ cells ( Figure  3a ± g ). This is particularly evident at 20 and 24 h after the start of the cell cycle. At these points respectively, 25 and 16% of the EFM7+/+ cell population, compared to 41 and 35% of the EFM47/7 cell population, were in G1 (Figure 3d,e) . At 28 h, we observed that the segment of EFM7+/+ cells in G1 increased again, indicating that these cells were entering a second cycle. Meanwhile the corresponding EFM47/7 population was still in the G1 phase with a continued increase in the population appearing in S phase (Figure 3f ). No signi®cant dierences were found in the sub-G1 (M1) portion of the scan suggesting that the cell population of either genotype did not display any signi®cant apoptotic events.
Retarded induction of cyclin D1 and slow degradation of p27 KIP1 in TC-PTP7/7 cells EFM7+/+ and EFM47/7 cells were synchronized in G0 by serum-starvation and expression of cyclin/CDKs complexes that control G1 phase progression were analysed upon restarting the cell cycle by addition of serum. For the early G1 phase, we checked for the induction of cyclin D1, CDK4 and degradation of p27 KIP1 . Protein extracts were prepared at the indicated time points and analysed by Western blotting ( Figure  4a ). In EFM7+/+ cells, there was a clear induction of cyclin D1 4 h after the cell cycle was restarted. In contrast, in EFM47/7 cells, cyclin D1 induction was observed only after 8 h of re-initiating the cell cycle ( Figure 4a , upper panel). The same blot was stripped and analysed for CDK4 expression. In EFM7+/+ and EFM47/7 cells, CDK4 levels did not change, consistent with the fact that its levels do not¯uctuate during the cell cycle (Figure 4a, middle panel) . Degradation of the CKI, p27 KIP1 , has been demonstrated to be required for the progression through G1 phase, allowing the activation of the cyclin E-CDK2 complex in late G1 phase. Levels of p27 KIP1 were high in serum-starved EFM7+/+ and EFM47/7 cells. After serum addition, a drastic reduction of p27 KIP1 was observed in EFM7+/+ cells by 12 h, but it remained at high levels even after 12 h in EFM47/7 cells (Figure 4a ).
Delayed activation of CDK2 and RB phosphorylation in late G1 phase in TC-PTP7/7 cells Defective expression of cyclin D1 in TC-PTP7/7 cells may have further consequences in the activation of subsequent cyclin/CDK complexes. Since cyclin D1 associates with CDK4 to phosphorylate RB until mid Oncogene Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al G1, and phosphorylated RB releases the E2F transcription factor to initiate transcription of several genes important for S phase transition, we checked the CDK2 activation by phosphorylation and in vitro kinase activity (Figure 4b,c) , as well as phosphorylation state of RB in G0 and late G1 phase (Figure 4b ). The active form of CDK2 migrating as the faster band (lower band representing active Thr-160 phosphorylated form) was increased by 20 h in EFM7+/+ cells, while in EFM47/7 cells, it was detectable only by 28 h ( Figure 4B , upper panel). In the EFM7+/+ cells, we observed an increase of 3.3 fold increase in activity of CDK2 over the basal level at 20 h, and 4.5-fold at 24 h. Meanwhile, in EFM47/7 cells the relative activity of CDK2 was 1.5 and 2.6 at 20 h and 24 h respectively (Figure 4c ). Finally, phosphorylation of RB was also delayed in EFM47/7 cells compared with EFM7+/+ cells. These results correlate with the delay of CDK4 and CDK2 activation observed in EFM47/7 cells (Figure 4b , lower panel). Together, these results con®rm that the absence of TC-PTP causes a major delay in the progression of the early G1 phase of the cell cycle.
Lack of TC-PTP does not affect cell cycle progression after the restriction point
In order to investigate whether the absence of TC-PTP was aecting other phases of the cell cycle, EFM7+/+ and EFM47/7 cells, as well as TC-PTP+/+ and TC-PTP7/7 primary MEFs were synchronized at the G1/S border with 1 mM of hydroxyurea for 16 h. We followed the progression through S phase at dierent time points after the block release. Approximately 40 ± 50% of the cells were in S phase 3 h after the block release without any statistically signi®cant dierences between both EFM7+/+ and EFM47/7 cells or TC-PTP+/+ and TC-PTP7/7 primary MEFs. Similar results were obtained after 6 h and 24 h (Table 1) These results show that TC-PTP7/7 cells do not present further defects in other phases of the cell cycle.
Absence of TC-PTP does not affect MAPK and Akt/PKB activation
Expression of cyclin D1 is in part attributed to a consequence of MAPK, PI3 kinase, and NF-kB activation. Since we observed a delayed cyclin D1 induction in TC-PTP7/7 cells, we investigated which of these signaling pathways were aected in the TC-PTP7/7 cells. First, we analysed the time course of ERK activation. EFM7+/+ and EFM47/7 cells released from quiescence by addition of PDGF did not show any dierences in ERK phosphorylation as determined by Western blot analysis using phosphospeci®c antibodies ( Figure 5a , upper panel). The same blot was stripped and probed for ERK expression ( Figure 5a , bottom panel), demonstrating that this MAPK pathway is not aected in TC-PTP7/7 cells.
Phosphatidylinositol 3,4,5-triphosphate (PIP3) is a product of PI3 kinase, which allows activation of the serine/threonine kinase Akt/PKB. In order to determine whether there was any defect in the PI3 kinase pathway in TC-PTP7/7 cells, we used Akt/PKB activation as a marker of PI3 kinase activity. Time course of activation of Akt/PKB in TC-PTP7/7 cells was determined by its phosphorylation on Ser473 at To con®rm that the Akt/PKB phosphorylation observed was due to PI3 kinase activation, we pre-treated quiescent EFM7+/+ and EFM47/7 cells with the PI3 kinase inhibitor LY-294002. Pre-treatment with LY-294002 abolished phosphorylation of Akt/PKB in both EFM7+/+ and EFM47/7 cells (Figure 5c ). Together these results suggest that the Akt/PKB activation after PDGF treatment is dependent on PI3 kinase and TC-PTP is not required for activating the PI3 kinase/Akt pathway.
Defective PDGF-induced IKK/NF-kB pathway in TC-PTP7/7 cells Recently, it has been suggested that activation of NFkB is required for increasing cyclin D1 levels. Phosphorylation of IkB on Ser32 and Ser36 by IkB kinase is necessary for its degradation and subsequent NF-kB activation. Since we observed a delayed induction of cyclin D1 in TC-PTP7/7 cells, we examined whether the NF-kB activation was aected in TC-PTP7/7 cells. EFM7+/+ and EFM47/7 cells were serum-starved and treated with PDGF or TNF. NF-kB activation was monitored by electrophoretic mobility shift assays using a 32 P labeled double-stranded oligonucleotide containing the NFkB binding site 739 to 730 bp of the cyclin D1 promoter, which previously was reported to be important for transcription of cyclin D1. PDGF and TNF treatment induced DNA-binding activity in EFM7+/+ cells. In contrast, in EFM47/7 cells, PDGF was unable to induce NF-kB DNA-binding activity. Importantly, TNF caused an appropriate activation (Figure 6a ), suggesting that the machinery was intact. Similar results were shown in the two other cell lines, EFM11+/+ and EFM147/7 (data not shown). Furthermore, supershift assays were performed in EFM7+/+ and EFM47/7 cells to identify which NF-kB subunits were activated by PDGF. We found that NF-kB complexes consisted of p65 and p50 subunits (data not shown). In order to determine whether defective NF-kB activation by PDGF was due to a problem in the phosphorylation of IkB by the IKK complex, we measured IKKb activity from serumstarved TC-PTP+/+ and TC-PTP7/7 cell lines treated with either PDGF or TNF. IKKb activity increased twofold in EFM7+/+ cells with PDGF or TNF treatment. However, in EFM47/7 cells, PDGF minimally activates IKKb, whereas TNF induced similar activation of IKKb compared with TNFinduced IKKb activity in EFM7+/+ cells ( Figure  6b,c) . Similar results were obtained with the EFM11 +/+ and EFM147/7 cell lines (Figure 6b ). This poor activation of IKKb in TC-PTP7/7 cells by PDGF correlates with defective DNA-binding activity of NF-kB. Phosphorylation of IkBa was veri®ed in TC-PTP+/+ and TC-PTP7/7 cells in response to PDGF. IkBa phosphorylation was induced by PDGF treatment at 5 min with a peak at 30 min in EFM7+/+ and EFM11+/+ cells, but was poorly phosphorylated in EFM47/7 and EFM147/7 cells, correlating with the defective activation of IKKb by PDGF (Figure 6d) . Interestingly, the amount of total IkB appears to be reduced in TC-PTP7/7 cells. Membranes were stripped and probed for CDK4 as loading control (Figure 6d ). These results suggest that the delayed expression of cyclin D1 in TC-PTP7/7 Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al Figure 3 Cell cycle progression of EFM7+/+ and EFM47/7 cells. Progression through the cell cycle of TC-PTP+/+ and TC-PTP7/7 cell lines was followed by FACS analysis. EFM7+/+ and EFM47/7 cells were synchronized by serum-starvation, trypsinized and plated in 10 cm-dishes at 1610 4 cells/cm 2 with DMEM plus 10% of FBS. Cells were allowed to progress through the cell cycle and trypsinized 0, 12, 16, 20, 24, 28 and 32 h after plating. Cells were ®xed with 4% paraformaldehyde, stained with 0.2 mg/ml of propidium iodide, and processed in a FACScan. The areas shown are M1 (Sub G1), M2 (G1), M3 (S), M4 (G2-M)
Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al cells is due to a failure in the activation of the IKK/ NF-kB pathway by PDGF.
Rescue of the TC-PTP7/7 phenotype by reintroducing wild-type TC-PTP
In order to con®rm that the defect in the cell proliferation and activation of NF-kB pathway leading to the expression of cyclin D1 was due to TC-PTP de®ciency, we infected EFM47/7 with a retrovirus containing a myc-tagged wild-type TC-PTP cDNA (myc-TC-PTP). We evaluated the expression of myc-TC-PTP by Western blotting. The rescued cell line (EFM4-R12) expresses half the amount TC-PTP compared to EFM7+/+ (Figure 7a, upper panel) . We also re-evaluated the proliferation rate in the rescued cells as well as in the parental cell lines. Since we showed that EFM4-R12 cells are not expressing the same amount of TC-PTP compared with the wild-type cells, it is expected that the proliferation would be less than the EFM7+/+ cells. Indeed, EFM4-R12 cells are partially rescued in their growth (Figure 7b) . Additionally, we tested the induction of cyclin D1 in the EFM4-R12 cells. We observed that after 4 h of reinitiating the cell cycle, EFM4-R12 cells express higher cyclin D1 levels than EFM47/7 cells (Figure 7c ). This is also consistent with the previous results (Figure 4a ). Furthermore, we tested the ability of PDGF or TNF to activate NF-kB in EFM4-R12 cells by gel shift assays.
The results show consistently that PDGF is able to activate NF-kB in EFM7+/+ cells, but not in EFM47/7 cells. In EFM4-R12 cells, this was partially rescued (Figure 7d ), once again correlating with the expression level of TC-PTP. Finally, the IkB levels and phosphorylation were also restored in EFM4-R12 cells in response to PDGF (Figure 7e ).
Discussion
In this study, we addressed the role of TC-PTP in cell proliferation by generating TC-PTP+/+ and TC-PTP7/7 primary MEFs as well as spontaneously established cell lines. We demonstrate that TC-PTP 7/7 cells present a reduced rate of proliferation that correlates with a longer G1 phase. Speci®cally, TC-PTP7/7 cells have a delayed induction of cyclin D1. These results unambiguously indicate that TC-PTP plays a positive role in cell proliferation and extends beyond overexpression studies of TC-PTP that suggest its potential role in proliferation (Nambirajan et al., 1995; Tillmann et al., 1994 , Tiganis et al., 1997 . In addition, it has been proposed that TC-PTP dephosphorylates the adaptor protein Shc and the EGF receptor. However, it is not clear how these reported substrates would explain the increase in cell proliferation (Tiganis et al., 1998) . We demonstrated that cells lacking TC-PTP have delayed cyclin D1 expression, slow degradation of the CKI p27 KIP1 , delayed activation of CDK2, and a prolonged RB hypophosphorylation. It is known that cyclin D1 levels rapidly increase after growth factor stimulation, promoting its association with CDK4. It has been suggested that the initial phosphorylation of RB by cyclin D1/CDK4 is required to induce its dissociation from the E2F transcription factor, that is responsible for the transcription of important genes for the G1/S transition including cyclin E and cyclin A (Hsiao et al., 1994; Johnson et al., 1994; Neuman et al., 1994 , Sherr, 1994 Fagan et al., 1994) . Progression of G1 phase is also regulated by CKIs, such as p27 KIP1 ,
MBP
Figure 4 G1-phase progression of EFM7+/+ and EFM47/7 cells. Expression of G1-phase cell cycle regulators in EFM7+/+ and EFM47/7 cells were analysed by Western blotting. (a) Western blot of EFM7+/+ and EFM47/7 protein extracts prepared at the indicated times after restarting the cell cycle by addition of serum. Induction of Cyclin D1 was detected by using a monoclonal antibody (upper panel). The blot was stripped and reprobed ®rst for expression of CDK4 (middle panel) and subsequently probed for p27 KIP1 (lower panel). (b) Activation CDK2 (upper panel) and RB phosphorylation (lower panel) were detected by Western blot analysis from serum starved EFM7+/+ and EFM47/7 cells. RB phosphorylation was detected using an antibody that recognizes dierent states of phosphorylation. (c) Activity of CDK2 was measured by immunoprecipitating protein extracts from EFM7+/+ and EFM47/7 at the times indicated with anti-CDK2 antibody and subjected to in vitro kinase assay in the presence of MBP as substrate. CDK2 activity was quanti®ed by phosphorimager (Fuji®lm) (upper panel). The membrane was probed with anti-CDK2 (bottom panel) which is highly expressed in quiescent cells inhibiting both cyclinD/CDK4 and cyclin E/CDK2 complexes (Nourse et al., 1994; Pagano et al., 1995; Hengst and Reed, 1996) . Titration of unbound p27 KIP1 with cyclin D1/CDK4 complex relieves cyclin E/CDK2, which then phosphorylates p27 KIP1 at Thr-187 triggering its degradation by the ubiquitin pathway (Shea et al., 1997; Vlach et al., 1997) . Since cyclin E/CDK2 complex is required for the degradation of p27 KIP1 , the fact that a slow rate of p27 KIP1 degradation is seen in TC-PTP7/7 cells correlates well with the delayed activation of CDK2, and with the hypophosphorylation of RB. We also demonstrated that TC-PTP+/+ and TC-PTP7/7 cells arrested at the G1/S border do Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al not present any defects in the progression through the rest of the cell cycle. Taken together our data con®rm that TC-PTP7/7 cells have a longer G1 phase than TC-PTP+/+ cells indicating that TC-PTP is required in the progression of G1 phase. Our ®ndings imply that TC-PTP serves as a positive regulator in early G1, probably through the induction of cyclin D1 expression. These results con®rm previous suggestions that overexpression of TC-PTP increase cell proliferation (Radha et al., 1997) . Since cyclin D1 delayed expression was the major defect observed in the TC-PTP7/7 cells, we examined various pathways required to induce maximum levels of cyclin D1. Previous studies on the Ras/Raf/Mek/ERK pathway have shown that speci®c activation of Ras or MEK induces expression of cyclin D1 (Woods et al., 1997; Kerkho and Rapp, 1997; Cheng et al., 1998 Cheng et al., , 1999 . However, we observed no dierences in PDGF stimulated MAPK activation monitored by phosphospeci®c antibodies to ERK1 and ERK2 in TC-PTP+/+ and TC-PTP7/7 cell lines. Recently, the role of the Ras/MAPK pathway has been downplayed in its contribution to cyclin D1 induction. The maximum peak of activation of the Ras/MAPK pathway occurs in minutes while the earliest expression of cyclin D1 is 4 h after release from quiescence (Gille and Downward, 1999) . Thus, other pathways must contribute to the optimal induction of cyclin D1.
Activation of PI3 kinase/Akt/PKB is another important pathway required for cyclin D1 expression. For example, quiescent cells treated with a PI3 kinase inhibitor had a considerable delay in cyclin D1 induction (Gille and Downward, 1999) . One important eector downstream of PI3 kinase is Akt/PKB. This kinase is needed for up-regulation of the cyclin D1 mRNA (Muise-Helmericks et al., 1998) and for stabilizing cyclin D1 protein (Diehl et al., 1998) . Upon examination, we were unable to detect any dierences in the activation of Akt/PKB in TC-PTP+/+ versus TC-PTP7/7 cells, and treatment with the PI3 kinase inhibitor LY294002 equally inhibits Akt/PKB phosphorylation in both genotypes. Hence, we conclude that TC-PTP is not required for PI3 kinase/Akt/PKB activation and that the delayed cyclin D1 induction in TC-PTP7/7 cells is likely via yet another signaling pathway. Figure 6 Activation of IKK/NF-kB pathway in TC-PTP+/+ and TC-PTP7/7 cells. Serum starved TC-PTP+/+ and TC-PTP7/7 cells were treated with either 50 ng/ml of PDGF-BB or 50 ng/ml of TNF-a for 1 h. (a) Electrophoretic mobility shift assay (EMSA) for NF-kB activity was performed using nuclear extracts from EFM7+/+ and EFM47/7 non treated and treated either with PDGF-BB or TNF-a for 1 h. (b) Protein extracts from EFM7+/+ and EFM47/7 cells were immunoprecipitated with anti-IKKb antibody and subjected to in vitro kinase assay in the presence of GST-IkB (1 ± 54) as substrate (upper panel). The membrane was probed with anti-IKKb (bottom panel). (c) IKKb activity from protein extracts from EFM7+/+, EFM11+/+, EFM47/7 and EFM147/7 cells was quanti®ed by phosphorimager (Fuji®lm). (d) Lysates from EFM7+/+, EFM47/7, EFM11+/+ and EFM147/7 cells were obtained at the time points indicated after PDGF-BB stimulation. IkBa phosphorylation was immunodetected using p-IkBa (Ser 32) (upper panel) and total IkBa (middle panel) antibodies. Membranes were stripped and probed with anti-CDK4 as loading control (bottom panel)
Oncogene Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al NF-kB was originally described as an important regulator of the immune and in¯ammatory response, but subsequently it has been shown that it also plays an important role in cell cycle progression and dierentiation. NF-kB induces the transcription of cyclin D1 and thereby aects the transition from G1 to S phase (Hinz et al., 1999; Guttridge et al., 1999) . We found that the NF-kB DNA-binding activity was reduced in TC-PTP7/7 cells following PDGF stimulation. In contrast, TNF can induce NF-kB DNA-binding activity in both TC-PTP+/+ and TC-PTP7/7 cells, indicating that the activation of NF-kB was not intrinsically defective. Consequently, we monitored the kinase activity of IKKb following PDGF or TNF treatment of the cells. In TC-PTP 7/7 cells, only the PDGF treatment showed a de®cient IKKb kinase activity. In contrast, TNFinduced IKKb kinase activity was normal in both TC-PTP+/+ and TC-PTP7/7 cells. These results are in accordance with the poor DNA-binding activity of NF-kB in TC-PTP7/7 cells. In support of these ®ndings, IkB phosphorylation was also reduced in the , and incubated in DMEM with 10% of serum. Proliferation was evaluated by MTT assays at 1, 3, 5 and 7 days after plating. (c) EFM7+/+, EFM47/7 and EFM4-R12 protein extracts were prepared at time 0 and 4 h after restarting the cell cycle by addition of serum. Western blot for cyclin D1 was detected by using a polyclonal antibody (upper panel). The membrane was stripped and reprobed for CDK4 (bottom panel). (d) Electrophoretic mobility shift assay (EMSA) for NF-kB activity was performed using nuclear extracts from EFM7+/+, EFM47/7 and EFM4-R12 as described in Figure 6a . (e) Cell lysates from EFM7+/+, EFM47/7 and EFM4-R12 were obtained at the time points indicated after PDGF-BB stimulation. IkBa phosphorylation (upper panel), total IkBa (middle panel) and CDK4 (bottom panel) was performed as in Figure 6d Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al TC-PTP7/7 cells. This points out that the delayed induction in cyclin D1 observed in TC-PTP7/7 cells is due to defective activation of the IKK/NF-kB pathway. A similar defective response to mitogens was reported in lymphocytes from NF-kB/Rel7/7 mice (Sha et al., 1995; Snapper et al., 1996; Liou, et al., 1999; Ferreira et al., 1999) . Interestingly, TC-PTP7/7 mice also present defective T-and B-cell proliferation (You-Ten et al., 1997) . It appears that TC-PTP may not be the only tyrosine phosphatase that signals through the NF-kB pathway to regulate a biological process. Recently, it was shown that Shp27/7 cells have nearly abolished IL-6 production by TNF and IL-1 through a defective NF-kB activation (You et al., 2001) . Signi®cantly, important dierences are observed between these two tyrosine phosphatases. For example, we do not observe any dierences in the activation of NF-kB by TNF in TC-PTP7/7 cells, whereas in Shp27/7 cells, this activation is defective. Moreover, in response to mitogens, Shp27/7 cells display poor MAPK activity whereas TC-PTP7/7 cells are defective in the NF-kB pathway. We do not discard the possibility that TC-PTP may play a role in another biological process involving signaling pathways dierent to the one described here. It is interesting to note that the EGF receptor, a putative substrate of TC-PTP, has recently been linked to NF-kB through a direct association with the NF-kB inducing kinase (NIK) and the TNF receptor interacting protein (RIP). This signaling complex is distinct from that involving the TNF receptor (Habib et al., 2001) . This raises the interesting possibility that TC-PTP might be involved in an intricate signaling pathway that integrates both growth factor receptors to the NF-kB pathway. In summary, we conclude that TC-PTP might act on a yet unidenti®ed substrate(s) that once dephosphorylated, positively aects the activation of the IKK/NFkB pathway following PDGF activation and perhaps stimulation with other growth factors. These ®ndings bring several clues that could facilitate the understanding of the proliferation defect seen in the T-and B-cells in the TC-PTP knockout mice and also establishes TC-PTP as a novel and important factor in cell proliferation.
Materials and methods
Murine embryonic fibroblast and cell lines generation
Mouse embryonic ®broblasts (MEFs) were isolated by trypsinization of littermate embryos dissected at 14 days of gestation from a cross of heterozygous TC-PTP mutant mice. Each embryo was harvested separately, the brain and internal organs were removed and the carcasses were minced and incubated with trypsin for 30 ± 45 min at 378C. Homogeneous cell suspensions were plated in 10 cm dishes in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% of fetal bovine serum (FBS), penicillin/streptomycin. Experiments with MEFs were performed in early passages (P56). Cells were expanded every 3 days until spontaneous cell lines were obtained. Genotyping was performed by Southern blot analysis, as previously described (You-Ten et al., 1997) . Primary TC-PTP+/+, TC-PTP7/7, EFM7+/+ and EFM47/7 cell lines were seeded in 24-well cell culture plates at a density of 1610 4 cells/cm 2 in DMEM with 10% FBS. Proliferation was quanti®ed by reduction of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) (as described in Mosmann, 1983) at day 1, 3, 5 and 7 after plating. Reintroduction of a myc-tagged wild-type TC-PTP into EFM47/7 cells was performed by retroviral infection using the pLXSH plasmid that confers resistance towards hygromycin.
Cell synchronization
G0 synchronization was performed by plating one million cells in a 10 cm dish and grown to con¯uence in DMEM supplemented with 10% FBS for 2 days. Fibroblasts were washed twice with PBS and incubated for 2 days with DMEM with 0.1% of FBS. Blocking at the G1/S border was made by incubating cells with 1 mM of hydroxyurea for 16 h. After this time cells were washed with PBS and the cell cycle was re-initiated by adding fresh media.
Cell cycle analysis
Synchronized cells were washed with PBS, trypsinized and seeded at 1610 4 cells/cm 2 in a 10 cm dish with DMEM+10% FBS. Cells were harvested by trypsinization at the time indicated, and ®xed with 4% paraformaldehyde for 30 min. They were then washed with PBS and kept in 70% ethanol overnight at 48C. Cells were centrifuged at 2000 r.p.m. and incubated at 378C in PBS containing 2 mg/ml of RNAase A (Boehringer Mannheim). Cells were stained with propidium iodide (PI; Sigma Chemical Co.) at a ®nal concentration of 0.2 mg/ml. Samples were processed by FACScan (Becton Dickinson).
Western blotting
Cells were lysed in a buer containing 0.1% NP-40, 125 mM NaCl, 25 mM Tris HCl pH 7.2, and protease inhibitor cocktail (Complete, EDTA-free; Boehringer Mannheim). Twenty micrograms of protein were fractionated by SDS ± PAGE and transferred to Immobilon-P PVDF membranes (Millipore Corp., Bedford, MA, USA). Immunodetection was performed with a chemiluminescence system (NEN Life Science Products). The primary antibodies were mouse monoclonal antibodies against TC-PTP (3E2), Cyclin D1 (A-12), pRB (PharMingen G3-245), p-MAPK (New England Biolabs), rabbit polyclonal antibodies against CDK4 (C-22), CDK2 (M-2), IKKb (H-470), IkBa (C-21) (Santa Cruz Biotechnology), p27 (Transduction labs), p-Akt (Ser 473), Akt, p-IkBa (Ser 32) IkBa (New England Biolabs). Horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies (Jackson Immunoresearch) were used for secondary detection. To prevent degradation of phospho-IkBa, cells were treated with proteosomal inhibitors MG-132 and ALLN (20 mM) for 2 h before stimulation.
Immuno complex kinase assays
Cells were treated with 50 ng/ml PDGF-BB or TNF-a for 30 min and lysed in a buer containing 50 mM HEPES (pH 7.4), 1 mM EDTA, 250 mM NaCl, 1% Nonidet P-40, protease inhibitor cocktail (Complete, EDTA-free; Boehringer Mannheim), 12.5 mM b-glycerophosphate, 2 mM NaF, 50 mM Na 3 VO 4 . Cell lysates were immunoprecipitated with Oncogene Defective activation of NF-kB and G1 phase progression in TC-PTP7/7 cells M de J Ibarra-Sa Â nchez et al anti-CDK2 or anti-IKKb antibody (Santa Cruz Biotechnology). Immunoprecipitates were washed three times with lysis buer and twice with kinase buer containing 10 mM HEPES (pH 7.4), 1 mM MnCl 2 , 5 mM MgCl 2 , 50 mM dithiothrietol, 12.5 mM b-glycerophosphate, 2 mM NaF, 50 mM Na 3 VO 4 and 10 mM ATP. Immunoprecipitates were incubated with 25 ml of kinase buer with 5 mCi of [g-32 P]ATP and 1 mg of MBP or GST ± IkB (1 ± 54) for 30 min at 308C. Kinase reactions were terminated by adding sample buer. The samples were run in SDS ± PAGE followed by transfer to Immobilon-P PVDF membranes (Millipore Corp., Bedford, MA, USA) and exposure to ®lm. Membranes were subsequently probed with anti-CDK2 or anti-IKKb.
Electrophoretic mobility shift assays
EMSAs were conducted using 10 mg of nuclear protein from serum-starved TC-PTP+/+ and TC-PTP7/7 cells stimulated with PDGF or TNF. Nuclear extracts were incubated with 32 P-labeled double-strand oligonucleotide corresponding the NF-kB consensus site (underlined) at 739 to 730 bp in the cyclin D1 promoter (5'-CTGCAGGGGAGTTTTGTT-GAAG-3') in a cocktail of HEPES 20 mM, pH 7.9, DTT 1 mM, KCl 50 mM, EDTA 0.2 mM, glycerol 10%, poly(pdIdC)-poly(dI-dC) 1 mg per reaction for 20 min. Complexes were run in 4% polyacrylamide gel. Gels were dried and exposed to a ®lm 4 h. Speci®c binding was determined by competition with cold probe. For supershift analysis 2 mg of antibody to p65 (A; Santacruz Biotechnology) or p50 (NLS; Santacruz Biotechnology) were pre-incubated for 20 min before adding the radiolabeled oligonucleotide.
